Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: A pediatric oncology group study
Terzah M. Horton
, Susan M. Blaney
,
Anne Marie Langevin
, John Kuhn
, Barton Kamen
, Stacey L. Berg
, Mark Bernstein
, Steven Weitman
Department of Pediatrics
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: A pediatric oncology group study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Antileukemic Agent
14%
Assessment
14%
Child
42%
Childhood Cancer
14%
Clearance
14%
Deoxyuridine
14%
Evaluation Study
14%
Infusion
14%
Leukemia
57%
Life
28%
Liver
14%
Measurement
14%
Observation
14%
Patient
14%
Pharmacokinetics
42%
Phase I Trials
28%
Plasma
14%
Thymidylate Synthase
14%
Toxicity
42%
Transaminase
14%
Volume of Distribution
14%
Pharmacology, Toxicology and Pharmaceutical Science
Aminotransferase
14%
Childhood Cancer
14%
Deoxyuridine
14%
Leukemia
57%
Maximum Tolerated Dose
28%
Pharmacokinetics
42%
Raltitrexed
100%
Thymidylate Synthase
14%
Toxicity
42%
Volume of Distribution
14%